BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 26919295)

  • 1. Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management.
    Iwaz JA; Maisel AS
    Expert Rev Mol Diagn; 2016 Jun; 16(6):641-50. PubMed ID: 26919295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of natriuretic peptides in the differential diagnosis of dyspnea].
    Špác J
    Vnitr Lek; 2016; 62(7-8):640-5. PubMed ID: 27627091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.
    Francis GS; Felker GM; Tang WH
    J Am Coll Cardiol; 2016 Jan; 67(3):330-7. PubMed ID: 26796399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors.
    Alawieh H; Chemaly TE; Alam S; Khraiche M
    Sensors (Basel); 2019 Nov; 19(22):. PubMed ID: 31744130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptides in heart failure and acute coronary syndrome.
    Gaggin HK; Januzzi JL
    Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
    Ibrahim N; Januzzi JL
    Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Place of natriuretic peptides in the early diagnosis of heart failure in community medicine].
    Galinier M; Cariou E; Lairez O; Fournier P; Delmas C; Biendel-Picquet C; Roncalli J
    Presse Med; 2018 Sep; 47(9):804-810. PubMed ID: 30293850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patients.
    Teixeira A; Arrigo M; Vergaro G; Cohen-Solal A; Mebazaa A
    Arch Gerontol Geriatr; 2017; 68():33-38. PubMed ID: 27611369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natriuretic peptides in heart failure].
    Emdin M; Poletti R; Giannoni A; Mazzei MG; Mammini C; Gabutti A; Agazio A; Caprioli R; Passino C
    G Ital Nefrol; 2006; 23 Suppl 34():S32-7. PubMed ID: 16633992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides in the diagnosis and management of acute heart failure.
    Mohammed AA; Januzzi JL
    Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptide testing in clinical medicine.
    Rehman SU; Januzzi JL
    Cardiol Rev; 2008; 16(5):240-9. PubMed ID: 18708825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical and clinical performance of three natriuretic peptide tests in the emergency room.
    Gorissen C; Baumgarten R; de Groot M; van Haren E; Kragten H; Leers M
    Clin Chem Lab Med; 2007; 45(5):678-84. PubMed ID: 17484634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure.
    Gruson D; Ahn SA; Rousseau MF
    Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of natriuretic peptides in heart failure: the good laboratory and clinical practice].
    Kovács LG; Nyolczas N; Habon T; Sepp R; Piroth Z; Hajas Á; Boncz I; Tomcsányi J; Kappelmayer J; Merkely B
    Orv Hetil; 2015 Aug; 156(31):1235-45. PubMed ID: 26211747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
    Bhardwaj A; Januzzi JL
    Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
    Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
    QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.